261 filings
Page 2 of 14
8-K
hz1oygv1
8 Jan 24
Departure of Directors or Certain Officers
6:45am
DEFA14A
kpghstkc
19 Dec 23
Additional proxy soliciting materials
8:32am
SC TO-C
kbqu2w4o2s
8 Dec 23
Information about tender offer
9:00am
PRE 14A
3clnktn
8 Dec 23
Preliminary proxy
8:30am
8-K
31r5xqo165y zukq1
7 Nov 23
Entry into a Material Definitive Agreement
7:39am
424B5
hypqv67zxrnkafpbi2
7 Nov 23
Prospectus supplement for primary offering
7:29am
8-K
qh3j4lireusu0aghon
7 Nov 23
Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
onk zlfop
31 Aug 23
Cost Associated with Exit or Disposal Activities
6:45am
S-8
vcbs7qmbbokqe7ki0
7 Aug 23
Registration of securities for employees
7:49am
8-K
g4kpq7dii
7 Aug 23
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
q76hcpjcuvt4v u50vol
16 Jun 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
cow x82t59krzr8h
7 Jun 23
Additional proxy soliciting materials
4:05pm
8-K
2hio9
2 May 23
Sage Therapeutics Announces First Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
ARS
qe0yrw5dtq0x9o757r
27 Apr 23
Annual report to shareholders
4:11pm
DEFA14A
m4slrtvg24diph
27 Apr 23
Additional proxy soliciting materials
4:08pm